Guidelines - M What are guidelines? / Guidelines A-Z

Macular Degeneration

• Age-related Macular Degeneration - Guidelines for Management, Royal College of Ophthalmologists (February 2009)
• Epiretinal brachytherapy for wet age related macular degeneration, NICE Interventional Procedure Guideline (December 2011)
• Guidance on the use of photodynamic therapy for age-related macular degeneration, NICE (2003)
• Implantation of miniature lens systems for advanced age-related macular degeneration, NICE Interventional Procedure Guideline (August 2008)
• Limited macular translocation for wet age-related macular degeneration, NICE Interventional Procedure Guideline (May 2010)
• Macular translocation with 360° retinotomy for wet age related macular degeneration, NICE Interventional Procedure Guideline (May 2010)
• Ocular Toxicity and Hydroxychloroquine: Guidelines for Screening, Royal College of Ophthalmologists and British Association of Dermatologists (2009)
• Pegaptanib and ranibizumab for the treatment of age-related macular degeneration, NICE Technology Appraisal Guideline (August 2008)
• Radiotherapy for age-related macular degeneration, NICE (2004)
• Ranibizumab: the clinician’s guide to commencing, continuing and discontinuing treatment; Royal College of Ophthalmologists (June 2008)
• The clinical effectiveness and cost effectiveness of photodynamic therapy for age related macular degeneration, NICE Technology Appraisal (Sept 2003)
• The Intravitreal use of Bevacizumab (Avastin) in Age Related Macular Degeneration, Royal College of Ophthalmologists (February 2009)
• Transpupillary thermotherapy for age-related macular degeneration, NICE (2004)

Malabsorption

• Nutrition support in adults: oral nutrition support, enteral tube feeding and parenteral nutrition; NICE (2006)

Malaria

• Guidelines for malaria prevention in travellers from the United Kingdom, Health Protection Agency (January 2007)
• Malaria treatment guidelines; Health Protection Agency
• The diagnosis and treatment of malaria in pregnancy, Green-top Guideline No. 54B, Royal College of Obstetricians and Gynaecologists (2010)

Malignant Melanoma Of Skin

• Referral for suspected cancer, NICE Clinical Guideline (2005)

Manic Depression

• Antenatal and postnatal mental health: clinical management and service guidance, NICE Clinical Guideline (2007)
• Bipolar affective disorder, Scottish Intercollegiate Guidelines Network - SIGN (2005)
• Evidence-based guidelines for treating bipolar disorder: revised second edition, British Association for Psychopharmacology (March 2009)
• Management of Women with Mental Health Issues during Pregnancy and the Postnatal Period, Royal College of Obstetricians and Gynaecologists (June 2011)
• Safer Lithium Therapy, National Patient Safety Agency (2009)
• Service user experience in adult mental health, NICE Clinical Guideline (December 2011)
• The clinical effectiveness and cost effectiveness of electroconvulsive therapy (ECT) for depressive illness, schizophrenia, catatonia and mania; NICE (2003)
• The Management of bipolar disorder in adults, children and adolescents, in primary and secondary care; NICE (2006)

Marfan Syndrome

• External aortic root support in Marfan syndrome, NICE Interventional Procedure Guideline (May 2011)

Mastectomy

• Endoscopic mastectomy and endoscopic wide local excision for breast cancer, NICE Interventional Procedure Guideline (April 2009)

Mastitis

• Guidelines on the Treatment, Management and Prevention of Mastitis; Guidelines & Audit Implementation Network (August 2009)

Me - Myalgic Encephalomyelitis

• Chronic fatigue syndrome / Myalgic encephalomyelitis (or encephalopathy) diagnosis and management, NICE Clinical Guideline (2007)
• Occupational aspects of the management of chronic fatigue syndrome: a national guideline, Dept of Health, 2006

Measles

• Guidance on Infection Control in Schools and other Childcare Settings, Health Protection Agency (April 2010)
• Guidance on Viral Rash in Pregnancy, Health Protection Agency (January 2011)
• Guidelines on Measles, Health Protection Agency (2010)
• Post-exposure Prophylaxis for Measles: Revised Guidance, Health Protection Agency (May 2009)

Medical Emergency

• Acutely ill patients in hospital , NICE Clinical Guidance (2007)

Medication Induced Headache

• Guidelines for All Healthcare Professionals in the Diagnosis and Management of Migraine, Tension-Type, Cluster and Medication-Overuse Headache; British Association for the Study of Headache - BASH (2010)
• Headaches: diagnosis and management of headaches in young people and adults, NICE Clinical Guideline (September 2012)

Melanoma

• EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force, European Federation of Neurological Societies (2006)
• Electrochemotherapy for metastases in the skin from tumours of non-skin origin, NICE IPG (Mar 2013)
• Endoscopic radical inguinal lymphadenectomy, NICE Interventional Procedure Guideline (June 2011)
• Guidelines for the management of cutaneous melanoma, British Association of Dermatologists (2010)
• Improving Outcomes for People with Skin Tumours including Melanoma, NICE (Update May 2010)
• Ipilimumab for previously treated advanced (unresectable or metastatic) melanoma; NICE technology appraisal (Dec 2012)
• Melanoma (BRAF V600 mutation positive, unresectable metastatic) - vemurafenib; NICE technology appraisal (Dec 2012)
• Melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up; European Society for Medical Oncology (2010)
• Referral for suspected cancer, NICE Clinical Guideline (2005)
• Skin cancer prevention: information, resources and environmental changes - how the NHS and local authorities can help prevent skin cancer using public information, sun protection resources and by making changes to the environment; NICE Public Health Guideline (January 2011)

Meniere's Disease

• Micropressure therapy for refractory Ménière's disease, NICE Interventional Procedure Guideline (April 2012)

Meningitis

• Bacterial meningitis and meningococcal septicaemia, NICE Clinical Guideline (June 2010)
• EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults, European Federation of Neurological Societies (2008)
• Management of invasive meningococcal disease in children and young people, Scottish Intercollegiate Guidelines Network - SIGN (May 2008)
• Managing meningococcal disease (septicaemia or meningitis) in higher education institutions, Universities UK (2004)
• Meningococcal disease, Health Protection Agency (various dates for various guidelines)
• Meningococcal Meningitis and Septicaemia - various guidelines, Meningitis Research Foundation (various dates)
• Viral meningoencephalitis: a review of diagnostic methods and guidelines for management, European Federation of Neurological Societies (2010)

Meningococcal Infection

• Bacterial meningitis and meningococcal septicaemia, NICE Clinical Guideline (June 2010)
• Guidance for public health management of meningococcal disease in the UK, Health Protection Agency (2011)
• Management of invasive meningococcal disease in children and young people, Scottish Intercollegiate Guidelines Network - SIGN (May 2008)
• Managing meningococcal disease (septicaemia or meningitis) in higher education institutions, Universities UK (2004)
• Meningococcal disease, Health Protection Agency (various dates for various guidelines)
• Meningococcal Meningitis and Septicaemia - various guidelines, Meningitis Research Foundation (various dates)

Meningoencephalitis

• Viral meningoencephalitis: a review of diagnostic methods and guidelines for management, European Federation of Neurological Societies (2010)

Menopause

• Alternative and complementary therapies consensus statement, British Menopause Society (2007)
• Alternatives to HRT for management of symptoms of menopause, Royal College of Obstetricians and Gynaecologists (September 2010)
• Contraception for Women Aged Over 40 Years, Faculty of Sexual and Reproductive Healthcare (2010)
• Hormone replacement therapy consensus statement, British Menopause Society (2008)
• Investigation of post-menopausal bleeding, Scottish Intercollegiate Guidelines Network - SIGN (2002)
• Non-estrogen based treatments for menopausal symptoms consensus statement, British Menopause Society (2008)
• Premature menopause consensus statement, British Menopause Society (2007)
• Urogenital atrophy consensus statement, British Menopause Society (2008)

Menorrhagia

• Balloon thermal endometrial ablation (using data from Cavaterm and Gynecare as specified by SERNIP), NICE (2003)
• Endometrial cryotherapy for menorrhagia, NICE (2006)
• Free fluid thermal endometrial ablation, NICE (2004)
• Heavy menstrual bleeding; NICE Clinical Guideline (January 2007)
• Impedance-controlled endometrial ablation for menstrual bleeding, NICE (2004)
• Menstrual bleeding - fluid-filled thermal balloon and microwave endometrial ablation, NICE (2004)
• Microwave endometrial ablation, NICE (2003)
• Photodynamic endometrial ablation, NICE (2004)

Mesothelioma

• BTS Statement on Malignant Mesothelioma, British Thoracic Society (2007)
• Lung cancer - the diagnosis and treatment of lung cancer; NICE Clinical Guideline (April 2011)
• Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up; European Society for Medical Oncology (2010)
• Management of malignant pleural mesothelioma, European Respiratory Society and the European Society of Thoracic Surgeons (2010)
• Mesothelioma - pemetrexed disodium, NICE Technology Appraisal (January 2008)
• Referral for suspected cancer, NICE Clinical Guideline (2005)

Methicillin Resistant Staph Aureus

• Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities, Hospital Infection Society et al (2006)
• Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK, Hospital Infection Society et al (2006)
• Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom, British Society for Antimicrobial Chemotherapy (2008)
• Guidelines for UK practice for the diagnosis and management of methicillin-resistant staphylococcus aureus MRSA infections presenting in the community, Journal of Antimicrobial Chemotherapy (2008)
• Staphylococcus aureus and MRSA (various), Health Protection Agency (various dates)

Migraine

• EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force, European Federation of Neurological Societies (August 2009)
• Guidelines for All Healthcare Professionals in the Diagnosis and Management of Migraine, Tension-Type, Cluster and Medication-Overuse Headache; British Association for the Study of Headache - BASH (2010)
• Headaches: diagnosis and management of headaches in young people and adults, NICE Clinical Guideline (September 2012)
• Migraine (chronic) - botulinum toxin type A, NICE Technology Appraisal Guideline (June 2012)
• Migraine related vertigo: classification and diagnostic criteria, British Association of Audiological Physicians (November 2008)
• Occipital nerve stimulation for intractable chronic migraine, NICE Interventional procedure guidance (April 2013)
• Percutaneous closure of patent foramen ovale for recurrent migraine, NICE Interventional Procedure Guideline (December 2010)

Migrainous Neuralgia

• EFNS guidelines on the treatment of cluster headache and other trigeminalautonomic cephalalgias, European Federation of Neurological Societies (2006)
• Guidelines for All Healthcare Professionals in the Diagnosis and Management of Migraine, Tension-Type, Cluster and Medication-Overuse Headache; British Association for the Study of Headache - BASH (2010)

Miscarriage

• Diagnosis and initial management in early pregnancy of ectopic pregnancy and miscarriage; NICE clinical guideline (Dec 2012)
• Laparoscopic cerclage for prevention of recurrent pregnancy loss due to cervical incompetence, NICE Interventional Procedure Guideline (2007)
• The Investigation and Treatment of Couples with Recurrent First-trimester and Second-trimester Miscarriage, Royal College of Obstetricians and Gynaecologists (April 2011)
• The Use of Anti-D Immunoglobulin for Rhesus D Prophylaxis, Royal College of Obstetricians and Gynaecologists (April 2011)

Mitochondrial Disease

• Guidelines on the molecular diagnosis of mitochondrial disorders, European Federation of Neurological Societies (2009)

Mitral Regurgitation

• Antimicrobial prophylaxis against infective endocarditis, NICE Clinical Guideline (March 2008)
• Antithrombotics: indications and management, Scottish Intercollegiate Guidelines Network - SIGN (August 2012)
• Management of Valvular Heart Disease, European Society of Cardiology (2012)
• Percutaneous mitral valve annuloplasty, NICE Interventional Procedure Guideline (July 2010)
• Percutaneous mitral valve leaflet repair for mitral regurgitation, NICE Interventional Procedure Guideline (August 2009)
• Thoracoscopically assisted mitral valve surgery, NICE Interventional Procedure Guideline (December 2007)

Mitral Stenosis

• Antimicrobial prophylaxis against infective endocarditis, NICE Clinical Guideline (March 2008)
• Antithrombotics: indications and management, Scottish Intercollegiate Guidelines Network - SIGN (August 2012)
• Management of Valvular Heart Disease, European Society of Cardiology (2012)
• Thoracoscopically assisted mitral valve surgery, NICE Interventional Procedure Guideline (December 2007)

Molluscum Contagiosum

• Guidance on Infection Control in Schools and other Childcare Settings, Health Protection Agency (April 2010)
• Management of molluscum contagiosum, British Association for Sexual Health and HIV (2007)
• Sexually Transmitted Infections in Primary Care, Royal College of General Practitioners and British Association for Sexual Health and HIV (Apr 2013)

Monoclonal Gammopathy

• Guidelines for the investigation of newly detected M-proteins and the management of Monoclonal Gammopathy of Undetermined Significance (MGUS), UK Myeloma Forum and Nordic Myeloma Study Group (February 2009)

Morphine

• Opioids for persistent pain: Good practice, British Pain Society (2010)

Motor Neurone Disease

• EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force, European Federation of Neurological Societies (2011)
• Guidelines on the use of neuroimaging in the management of motor neuron diseases, European Federation of Neurological Societies (2010)
• Long-term neurological conditions - management at the interface between neurology rehabilitation and palliative care, Royal College of Physicians (March 2008)
• Motor neurone disease - non-invasive ventilation, NICE Clinical Guideline (July 2010)
• Motor neurone disease, NICE (2001)

Mouth Problems

• Guidelines for the management of oral lichen planus in secondary care, British Society for Oral Medicine (2010)
• Multi-disciplinary Guidelines for the Oral Management of Patients following Oncology Treatment, Royal College of Surgeons of England and The British Society for Disability and Oral Health (2012)

Mrsa

• Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities, Hospital Infection Society et al (2006)
• Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK, Hospital Infection Society et al (2006)
• Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom, British Society for Antimicrobial Chemotherapy (2008)
• Guidelines for UK practice for the diagnosis and management of methicillin-resistant staphylococcus aureus MRSA infections presenting in the community, Journal of Antimicrobial Chemotherapy (2008)
• Staphylococcus aureus and MRSA (various), Health Protection Agency (various dates)

Mucopolysaccharidosis

• Guidelines for the investigation and management of mucopolysaccharidosis type I, Dept of Health (2005)
• Guidelines for the investigation and management of mucopolysaccharidosis type II, Dept of Health (2007)
• Guidelines for the investigation and management of mucopolysaccharidosis type VI, Dept of Health (2006)

Multifocal Motor Neuropathy

• European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy, European Federation of Neurological Societies (2006)

Multiple Endocrine Neoplasia

• Paediatric Endocrine Tumours, British Society for Paediatric Endocrinology and Diabetes (2005)

Multiple Myeloma

• Bortezomib and thalidomide for the first-line treatment of multiple myeloma, NICE Technology Appraisal Guideline (July 2011)
• Bortezomib monotherapy for relapsed multiple myeloma, NICE Technology Appraisal (October 2007)
• Guidelines for the investigation of newly detected M-proteins and the management of Monoclonal Gammopathy of Undetermined Significance (MGUS), UK Myeloma Forum and Nordic Myeloma Study Group (February 2009)
• Guidelines for the use of imaging in the management of myeloma, British Committee for Standards in Haematology (2006)
• Lenalidomide for the treatment of multiple myeloma in people who have received at least one prior therapy, NICE Technology Appraisal (June 2009)
• Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up; European Society for Medical Oncology (2010)
• Supportive care in multiple myeloma, British Committee for Standards in Haematology (October 2010)
• The diagnosis and management of multiple myeloma, British Committee for Standards in Haematology (October 2010)

Multiple Sclerosis

• EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis, European Federation of Neurological Societies (2006)
• Long term neurological conditions - a good practice guide to the development of the multidisciplinary team and the value of the specialist nurse, NHS National Workforce Projects in partnership with the Multiple Sclerosis Society, Epilepsy Action, the Parkinson’s Disease Society, the Royal College of Nursing and Dept of Health (May 2008)
• Long-term neurological conditions - management at the interface between neurology rehabilitation and palliative care, Royal College of Physicians (March 2008)
• Multiple sclerosis - beta interferon and glatiramer acetate, NICE Technology Appraisal Guidance (January 2002)
• Multiple Sclerosis - Management of multiple sclerosis in primary and secondary care, NICE Guidance (November 2003)
• Multiple sclerosis (relapsing-remitting) - fingolimod, NICE Technology Appraisal Guideline (April 2012)
• Natalizumab for the treatment of adults with highly active relapsing-remitting multiple sclerosis, NICE Technology Appraisal (2007)
• Percutaneous venoplasty for chronic cerebrospinal venous insufficiency for multiple sclerosis, NICE Interventional Procedure Guideline (March 2012)
• Prescribing in multiple sclerosis - Association of British Neurologists' guidelines, Association of British Neurologists (2009)
• Urinary incontinence in neurological disease, NICE Clinical guideline (Aug 2012)

Mumps

• Guidance on Infection Control in Schools and other Childcare Settings, Health Protection Agency (April 2010)
• Guidelines on Mumps, Health Protection Agency (various dates)

Mumps Encephalitis

• Viral meningoencephalitis: a review of diagnostic methods and guidelines for management, European Federation of Neurological Societies (2010)

Muscle Disorders

• Guidelines for the respiratory management of children with neuromuscular weakness, British Thoracic Society (2012)
• Guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia, European Federation of Neurological Societies (2010)

Muscular Dystrophy

• EFNS guideline on diagnosis and management of limb girdle muscular dystrophies, European Federation of Neurological Societies (2007)
• Guidelines for the respiratory management of children with neuromuscular weakness, British Thoracic Society (2012)

Musculoskeletal Chest Problems

• Guidelines for the respiratory management of children with neuromuscular weakness, British Thoracic Society (2012)
• Insertion of metal rib reinforcements to stabilise a flail chest wall, NICE Interventional Procedure Guideline (October 2010)

Myasthenia Gravis

• Clinical Guidelines for Immunoglobulin Use (second edition), Dept of Health, May 2008
• Guidelines for the treatment of autoimmune neuromuscular transmission disorders, European Federation of Neurological Societies (2010)

Mycosis Fungoides

• Guidelines for the Management of Primary Cutaneous T-cell Lymphomas, British Association of Dermatologists (2003)
• Guidelines on the diagnosis and management of adult patients with primary CNS lymphoma (PCNSL) and primary intra-ocularlymphoma (PIOL); British Committee for Standards in Haematology (2007)
• The management of mature T-cell and NK-cell neoplasms, British Committee for Standards in Haematology (2011)

Myelodysplastic Syndromes

• Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes, British Committee for Standards in Haematology (2003)
• Myelodysplastic syndromes - azacitidine, NICE Technology Appraisal Guideline (March 2011)

Myeloma

• Bortezomib and thalidomide for the first-line treatment of multiple myeloma, NICE Technology Appraisal Guideline (July 2011)
• Bortezomib monotherapy for relapsed multiple myeloma, NICE Technology Appraisal (October 2007)
• Guidelines for the investigation of newly detected M-proteins and the management of Monoclonal Gammopathy of Undetermined Significance (MGUS), UK Myeloma Forum and Nordic Myeloma Study Group (February 2009)
• Guidelines for the use of imaging in the management of myeloma, British Committee for Standards in Haematology (2006)
• Lenalidomide for the treatment of multiple myeloma in people who have received at least one prior therapy, NICE Technology Appraisal (June 2009)
• Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up; European Society for Medical Oncology (2010)
• Supportive care in multiple myeloma, British Committee for Standards in Haematology (October 2010)
• The diagnosis and management of multiple myeloma, British Committee for Standards in Haematology (October 2010)

Myeloproliferative Disorders

• Acute myeloblastic leukaemias and myelodysplastic syndromes in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up; European Society for Medical Oncology (2010)
• Guideline for the diagnosis and management of myelofibrosis, British Committee for Standards in Haematology (2012)

Myocardial Infarction

• Acute coronary syndrome - prasugrel, NICE Technology Appraisal Guideline (October 2009)
• Acute coronary syndromes - ticagrelor, NICE Technology Appraisal Guideline (October 2011)
• Acute coronary syndromes, Scottish Intercollegiate Guidelines Network - SIGN (Feb 2013)
• Angina and myocardial infarction - myocardial perfusion scintigraphy, NICE Technology Appraisal (2003)
• Cardiac arrhythmias in coronary heart disease, Scottish Intercollegiate Guidelines Network - SIGN (2007)
• Chest pain of recent onset, NICE Clinical Guideline (March 2010)
• Consensus guideline for recording a 12-lead ECG, Society for Cardiological Science & Technology (February 2010)
• Fitness to fly for passengers with cardiovascular disease, British Cardiovascular Society (May 2010)
• Guidelines for Myocardial Revascularisation, European Society of Cardiology (2010)
• Hyperglycaemia in acute coronary syndromes, NICE Clinical Guideline (October 2011)
• Ischaemic heart disease - coronary artery stents, NICE Technology Appraisal (2003)
• Management of Acute Coronary Syndromes (ACS) in patients presenting without persistent ST-segment elevation, European Society of Cardiology (2011)
• Management of Acute Myocardial Infarction in patients presenting with ST-segment elevation, European Society of Cardiology (2012)
• Myocardial infarction (persistent ST-segment elevation) - bivalirudin, NICE Technology Appraisal Guideline (July 2011)
• Secondary prevention in primary and secondary care for patients following a myocardial infarction, NICE Clinical Guideline (2007)
• Third Universal Definition of Myocardial Infarction, European Society of Cardiology (2012)
• Unstable angina and NSTEMI, NICE Clinical Guideline (March 2010)
• Vascular disease - clopidogrel and dipyridamole, NICE Technology Appraisal Guideline (December 2010)

Myopia

• Corneal implants for the correction of refractive error, NICE Interventional Procedure Guideline (2007)
• Intraocular lens insertion for correction of refractive error with preservation of the natural lens, NICE Interventional Procedure Guideline (February 2009)
• Laser correction of refractive error following non-refractive ophthalmic surgery, NICE Interventional Procedure Guideline (March 2011)
• Laser in situ keratomileusis (LASIK), NICE (2004)
• Photorefractive (laser) surgery for the correction of refractive error, NICE (2006)
• Standards for laser refractive surgery, Royal College of Ophthalmologists (May 2009)